The CRI Irvington Postdoctoral Fellowship Program supports early-career scientists in immunology and cancer immunology research, fostering innovation and leadership through funding and mentorship from the Cancer Research Institute.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
Graduate Fellowship in Biomedical Research and Data Science supports doctoral researchers in data-driven cancer research to advance discovery, early detection, treatment, and patient benefit.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.